175 related articles for article (PubMed ID: 9316303)
1. Achondroplasia: recent advances in diagnosis and treatment.
Tanaka H
Acta Paediatr Jpn; 1997 Aug; 39(4):514-20. PubMed ID: 9316303
[TBL] [Abstract][Full Text] [Related]
2. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
Mancilla EE; Poggi H; Repetto G; García C; Foradori A; Cattani A
Rev Med Chil; 2003 Dec; 131(12):1405-10. PubMed ID: 15022403
[TBL] [Abstract][Full Text] [Related]
3. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
[TBL] [Abstract][Full Text] [Related]
4. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
van Ravenswaaij-Arts CM; Losekoot M
Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167
[TBL] [Abstract][Full Text] [Related]
5. [Updated treatment of achondroplasia].
Seino Y
Clin Calcium; 2009 Mar; 19(3):432-6. PubMed ID: 19252254
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone therapy in achondroplasia.
Seino Y; Yamanaka Y; Shinohara M; Ikegami S; Koike M; Miyazawa M; Inoue M; Moriwake T; Tanaka H
Horm Res; 2000; 53 Suppl 3():53-6. PubMed ID: 10971105
[TBL] [Abstract][Full Text] [Related]
7. Pseudoachondroplastic dysplasia.
Khungar A; Mahajan P; Gupte G; Vasundhara M; Kher A; Bharucha BA
J Postgrad Med; 1993; 39(2):91-3. PubMed ID: 8169872
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia.
Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A
Horm Res; 1996; 45(1-2):108-10. PubMed ID: 8742128
[TBL] [Abstract][Full Text] [Related]
9. [Differentiation of achondroplasia and other similar genetic dwarfism by FGFR3 gene analysis].
Zhang Y; Yu W; Shen M; Fang Q; Fan M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):252-5. PubMed ID: 10932008
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfism.
Aviezer D; Golembo M; Yayon A
Curr Drug Targets; 2003 Jul; 4(5):353-65. PubMed ID: 12816345
[TBL] [Abstract][Full Text] [Related]
11. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.
Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101
[TBL] [Abstract][Full Text] [Related]
12. Lethal skeletal dysplasia owing to double heterozygosity for achondroplasia and spondyloepiphyseal dysplasia congenita.
Young ID; Ruggins NR; Somers JM; Zuccollo JM; Rutter N
J Med Genet; 1992 Nov; 29(11):831-3. PubMed ID: 1453438
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
Shiang R; Thompson LM; Zhu YZ; Church DM; Fielder TJ; Bocian M; Winokur ST; Wasmuth JJ
Cell; 1994 Jul; 78(2):335-42. PubMed ID: 7913883
[TBL] [Abstract][Full Text] [Related]
14. [Hypochondroplasia: importance of radiological findings in the differential diagnosis of short statures of different origin].
Iannaccone R; Tiberti AC
Recenti Prog Med; 2001; 92(7-8):483-8. PubMed ID: 11475794
[TBL] [Abstract][Full Text] [Related]
15. Molecular defects in achondroplasia and the effects of growth hormone treatment.
Seino Y; Moriwake T; Tanaka H; Inoue M; Kanzaki S; Tanaka T; Matsuo N; Niimi H
Acta Paediatr Suppl; 1999 Feb; 88(428):118-20. PubMed ID: 10102070
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 (FGFR3) in Portugal.
Almeida MR; Campos-Xavier AB; Medeira A; Cordeiro I; Sousa AB; Lima M; Soares G; Rocha M; Saraiva J; Ramos L; Sousa S; Marcelino JP; Correia A; Santos HG
Clin Genet; 2009 Feb; 75(2):150-6. PubMed ID: 19215249
[TBL] [Abstract][Full Text] [Related]
17. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of achondroplasia using the nested polymerase chain reaction with modified primer sets.
Sawai H; Komori S; Tanaka H; Bessho T; Koyama K
Fetal Diagn Ther; 1996; 11(6):407-13. PubMed ID: 9115628
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the treatment of achondroplasia.
Yamanaka Y; Ueda K; Seino Y; Tanaka H
Horm Res; 2003; 60 Suppl 3():60-4. PubMed ID: 14671399
[TBL] [Abstract][Full Text] [Related]
20. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
Naski MC; Wang Q; Xu J; Ornitz DM
Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
